Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Video
Will Biosimilars Impact the Cost of Specialty Drugs?
Author(s):
Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses whether the R&D cost for biosimilars will affect the overall cost reduction.
Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses whether the R&D cost for biosimilars will affect the overall cost reduction.
Related Videos
Related Content
